HopeStage
Back to all studies
CompletedNCT07413692

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women

Device studyAges 22–60United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: 22 years to 60 years.

Listed locations
Garfield Heights and 2 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: November 25, 2025
Recruitment status
Completed
Enrollment listed in the registry
30
Sponsor
BTL Industries Ltd.
Sponsor type
Other organization
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 22 Years to 60 Years
Official registry ID
NCT07413692
Official title
Show the full official title

Safety and Efficacy of the Combined BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence Among Postpartum Women and Women up to Five Years After Childbirth

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Garfield Heights · Oklahoma City · Dallas

FAQ

Questions about this study

Who is behind this study?

The study sponsor is BTL Industries Ltd.

Who was this study for?

Listed age limits: 22 years to 60 years.

Want to explore more studies?

Explore studies